pentobarbital will minimize the level or outcome of suvorexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Strong CYP3A4 inducers might reduce suvorexant efficacy; if greater suvorexant dose required, will not exceed twenty mg/working dayCheck Carefully (1)pentobarbital will lower the extent or outcome of g